Precigen (PGEN) Other Non Operating Income (2012 - 2026)
Precigen's (PGEN) quarterly Other Non Operating Income came in at $290000.0 in Q1 2026, up 4042.86% year-on-year from $7000.0 in Q1 2025, and up 383.33% on a QoQ basis from $60000.0 in Q4 2025.
Precigen (PGEN) Other Non Operating Income (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Other Non Operating Income data on file, last reported at $290000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 4042.86% year-over-year to $290000.0 in Q1 2026; TTM through Mar 2026 was $326000.0, a 94.14% decrease from a year earlier, with the FY2025 full-year figure at $43000.0, down 99.23% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $290000.0, up from $60000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for PGEN reached as high as $8.5 million in Q4 2024 and fell as low as -$3.0 million in Q3 2024.
- Historically, Other Non Operating Income has averaged $476117.6 across 5 years, with a median of $44000.0 in 2023.
- Across the five-year window, Other Non Operating Income surged 13250.0% in 2022 and tumbled 1162.28% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at $263000.0 in 2022, then plunged by 129.66% to -$78000.0 in 2023, then surged by 10997.44% to $8.5 million in 2024, then slumped by 99.29% to $60000.0 in 2025, then soared by 383.33% to $290000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $290000.0 in Q1 2026, $60000.0 in Q4 2025, and $7000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 290,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | -31,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 8.50 Mn |
| Sep 30, 2024 | -2.99 Mn |
| Jun 30, 2024 | 43,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | -78,000.00 |
| Sep 30, 2023 | 281,000.00 |
| Jun 30, 2023 | 44,000.00 |
| Mar 31, 2023 | 380,000.00 |
| Dec 31, 2022 | 263,000.00 |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 40,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -133,000.00 |
| Jun 30, 2021 | -199,000.00 |